<?xml version="1.0" encoding="UTF-8"?>
<p id="p0420">Furthermore, m396, CR3014 
 <xref rid="b0780" ref-type="bibr">[156]</xref>, and Meplazumab (which is an anti-CD147 Mab 
 <xref rid="b0785" ref-type="bibr">[157]</xref>, could be alternative monoclonal antibodies to be used against SARS-CoV-2 
 <xref rid="b0765" ref-type="bibr">[153]</xref>. So, mAbs can be considered as potential therapeutic options against COVID-19.
</p>
